Why is Fresh Frozen Plasma (FFP) administered after transfusing 3 units of Packed Red Blood Cells (PRBCs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why FFP is Given After 3 Units of PRBCs

The traditional practice of giving FFP after 3 units of PRBCs is outdated and not supported by current evidence; modern massive transfusion protocols recommend early FFP administration at higher ratios (1:1 to 1:2 FFP:PRBC) from the start of resuscitation, not after an arbitrary number of PRBC units. 1

Evolution of Transfusion Practice

The historical approach was based on flawed assumptions about dilutional coagulopathy:

  • Old paradigm: FFP was traditionally given when PT or APTT exceeded 1.5 times normal OR after 10 RBC units had been transfused, with many protocols stipulating 1 unit FFP for every 4 units PRBCs 1
  • Current understanding: Trauma-induced coagulopathy occurs early and is not purely dilutional—it results from consumption of hemostasis factors at injury sites and systemic coagulation activation 1

Evidence-Based Rationale for Early High-Ratio FFP

Military and civilian data demonstrate that early high-ratio FFP transfusion (approaching 1:1 or at minimum 1:2) significantly reduces mortality compared to delayed or low-ratio strategies:

  • Casualties receiving FFP:PRBC ratios of 1:4 or lower had three-fold higher mortality than those receiving 2:3 ratios 1
  • FFP:PRBC ratios ≥1:1.5 are independently associated with 52% lower mortality risk after controlling for confounders 2
  • The mortality benefit from high FFP:PRBC ratios applies to ALL massively transfused trauma patients, regardless of admission INR 3

Optimal FFP:PRBC Ratio

The evidence suggests ratios between 1:2 and 1:1 provide maximal benefit:

  • Ratios of 1:2 to 3:4 show maximal hemostatic effect: 12% decrease in PT, 56% decrease in clotting time, and 38% increase in clot firmness 4
  • Ratios ≥1:1 do not confer additional hemostatic advantage over 1:2 to 3:4 ratios 4
  • Seven studies showed better outcomes with high FFP:RBC ratios, while only two did not 1

Current Guideline Recommendations

European trauma guidelines recommend early FFP treatment in massive bleeding, not delayed administration:

  • Initial recommended dose is 10-15 ml/kg FFP 1
  • FFP should be given early in thawed form for patients with massive bleeding (Grade 1B recommendation) 1
  • Further FFP doses depend on coagulation monitoring and amount of other blood products administered 1

Critical Pitfalls to Avoid

Waiting for laboratory confirmation or arbitrary PRBC thresholds delays life-saving treatment:

  • Do not wait for PT/APTT results before initiating high-ratio FFP in massive hemorrhage—coagulopathy is present early 1, 3
  • Do not use outdated 1:4 ratios or wait until 10 units of PRBCs have been given 1
  • Recognize that FFP benefits are confined to patients with actual or impending coagulopathy, not prophylactic use in non-bleeding patients 4

Important Safety Considerations

FFP carries significant risks that must be balanced against benefits:

  • FFP is associated with transfusion-related acute lung injury (TRALI), circulatory overload, ABO incompatibility, and infectious disease transmission 1
  • FFP and platelet concentrates are the most frequently implicated products in TRALI 1
  • Early empirical FFP may increase delayed traumatic intracerebral hematoma frequency in severe head injury 1
  • High FFP:PRBC ratios (≥1:1.5) are associated with almost twofold higher risk of acute respiratory distress syndrome 2

Alternative Strategies

Fibrinogen concentrate and cryoprecipitate are superior to FFP for correcting hypofibrinogenemia:

  • FFP should be avoided for hypofibrinogenemia correction if fibrinogen concentrate or cryoprecipitate are available 1
  • FFP contains only ~70% normal levels of clotting factors and shows wide variability in fibrinogen content 1
  • The RETIC trial showed FFP was insufficient to correct hypofibrinogenemia compared to fibrinogen concentrate, with 52% of FFP patients requiring rescue CFC therapy versus only 4% in the CFC group 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.